Target intelligence / Profile preview

Phosphatidylinositol glycan anchor biosynthesis, class P pseudogene

Molecular classification: Other

Overview

The "phosphatidylinositol glycan anchor biosynthesis, class P pseudogene" represents a non-protein-coding genomic element similar in sequence to the functional PIGP gene. It does not encode a functional protein, is not involved in biosynthetic pathways, and has no known therapeutic relevance, biological activity, or disease involvement. The active PIGP gene encodes an enzyme required for the first step in glycosylphosphatidylinositol (GPI) anchor biosynthesis—a crucial process for anchoring proteins to the cell membrane—but the pseudogene has no such function[1].

Beyond the preview

Go deeper on Phosphatidylinositol glycan anchor biosynthesis, class P pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol glycan anchor biosynthesis, class P pseudogene.

Explore the full profile